Breaking News: Regenxbio and Nippon Shinyaku Join Forces to Fight MPS Diseases with RGX-121 and RGX-111 Description: REGENXBIO to receive $110 million upfront, potential milestone payments of up to $700 million and meaningful double-digit royalties on net sales, and lead manufacturing Nippon Shinyaku to lead commercialization of first potential gene
A Look into Carlisle Companies’ Business Transformation and its Impact on Shareholders Carlisle Companies’ Strategic Pivot Carlisle Companies has made a remarkable transformation in its business strategy, shifting towards high-ROIC building products. This strategic pivot has not only significantly enhanced shareholder value but has also outperformed the S&P 500. Over
Glacier Bancorp Inc. Expands with Acquisition of Bank of Idaho Holding Co.! Description: KALISPELL, Mont., Jan. 13, 2025 (GLOBE NEWSWIRE) — Glacier Bancorp, Inc. (“Glacier” or the “Company”) (NYSE: GBCI) today announced the signing of a definitive agreement to acquire Bank of Idaho Holding Co. (“BOID”) (OTCQX: BOID), the bank
Breaking News: Piedmont Office Realty Trust Inc. Set to Reveal Fourth Quarter and Annual 2024 Financial Results! Description: Atlanta, Jan. 13, 2025 (GLOBE NEWSWIRE) — Piedmont Office Realty Trust (NYSE: PDM) announced today that the Company will release its fourth quarter and annual financial results on Thursday, February 13, 2025,
EVS Broadcast Equipment Announces Exciting Update to Share Buyback Program! EVS reports update of share buyback program Liège, Belgium | January 13, 2025 EVS Broadcast Equipment has reported an update on its share buyback program. The transactions, which were conducted within the framework of the program announced on November 25,
Calling All Investors: Join the Fight Against United Airlines for Securities Law Violations – The Schall Law Firm Wants You! Investigating Securities Law Violations at United Airlines LOS ANGELES, CA / ACCESSWIRE / January 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, has announced that
Revance Therapeutics Inc. Faces Legal Action for Securities Law Breaches – What Investors Need to Know Introduction Revance Therapeutics Inc., a well-known pharmaceutical company, is currently facing legal action for alleged breaches of securities laws. This has raised concerns among investors and has led to a class action lawsuit being
Breaking News: Concrete Pumping Holdings Launches Senior Secured Second Lien Notes Offering! DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the “Company”) announced today that Brundage-Bone Concrete Pumping Holdings Inc. (the “Issuer”), a wholly-owned subsidiary of the Company, intends to offer, on a private placement basis,
Revolutionizing Treatment: FDA Grants Breakthrough Therapy Designation to Letetresgene Autoleucel for Myxoid/Round Cell Liposarcoma (MRCLS) The field of oncology continues to see groundbreaking advancements in treatment options, with the latest development being the FDA granting breakthrough therapy designation to letetresgene autoleucel (lete-cel) for the treatment of patients with unresectable or
Unlocking the Future: Precigen’s Exciting Plans for PRGN-2012 Revealed at the 43rd Annual JP Morgan Healthcare Conference The realm of biopharmaceuticals is continually evolving, with companies like Precigen, Inc. at the forefront of groundbreaking advancements in gene and cell therapies. At this year’s highly anticipated 43rd Annual JP Morgan Healthcare
Attention Bioa Stockholders: Take Action Now with Bronstein Gewirtz and Grossman LLC Recover Your Losses from Bioage Labs Inc! NEW YORK CITY, NY / ACCESSWIRE / January 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
Attention Investors: Take Action Now! Transocean Ltd Faces Lawsuit for Significant Losses, Robbins Geller Rudman & Dowd LLP Reports SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Transocean Ltd. (NYSE: RIG) securities between October 31, 2023 and September
Unlocking the Secrets of the Human Body: Illumina’s Groundbreaking Proteomics Program Exploring the Depths of Human Biology In a groundbreaking move, Illumina, a global leader in DNA sequencing and array-based technologies, has announced a new proteomics program in collaboration with UK Biobank and several biopharma partners. This innovative program aims
Uncovering the Hidden Gems: A Look into Guardian Metal Resources PLC’s Pilot Mountain Industrial Garnet Findings Description: Guardian Metal Resources PLC, a strategic mineral exploration and development company, has recently announced significant industrial garnet findings at their Pilot Mountain Project in Nevada, USA. The company completed a metallurgical processing study
Breaking News: FDA Approves Roche’s Revolutionary Test for Detecting B-Cell Lymphoma Description: The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity to assess the full spectrum of B-cell lymphoma subtypes. The test helps differentiate a B-cell
Calling All PACS Investors: Take Action Against Securities Fraud with The Schall Law Firm! Introduction LOS ANGELES, Jan. 12, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, has announced the filing of a class action lawsuit against PACS Group, Inc. (“PACS” or “the Company”) (NYSE:
Risk Disclaimer: Sigmanomics is a financial portal that provides news and analysis about the different financial markets. The articles that we serve on the portal depend solely on the opinion and analysis of our economists which in no way are intended to incite a visitor of the website or an investor to trade or sell/buy a certain instrument. It is the responsibility of the visitor / trader only to evaluate his trading strategies and whether he is capable of trading with taking into consideration that losing all the capital invested is a possibility. The visitor should seek an independent professional financial advisor to discuss his or her trading strategies. Moreover, the provided rates for the different instruments are indicative only and cannot be used for trading purposes. Therefore, no responsibility can be imposed on sigmanomics.com.com and the company operating the portal for any loss of money that may occur to the visitor by using the website.
